<?xml version="1.0" encoding="UTF-8"?>
<p>In an uncontrolled case series, the treatment of five patients with severe SARS-CoV-2 infection and ARDS with CP showed clinical improvement in all five cases. All of these patients showed stabilization in their vital signs, decrease in inflammatory biomarkers (CRP, IL-6 and procalcitonin), and improvement of abnormalities on imaging. Three out of five of these patients were successfully extubated (
 <xref rid="B112" ref-type="bibr">112</xref>). Another study showed that the use of CP in 10 patients with severe SARS-CoV-2 infection resulted in significant clinical improvement with no side effects. All patients had disappearance of viremia within 7 days, improvement in their clinical symptoms, and improvement in their chest radiographic abnormalities (
 <xref rid="B111" ref-type="bibr">111</xref>).
</p>
